3 months ago
19
Skip to navigation Skip to main contented Skip to close file
TipRanks
Thu, January 1, 2026 astatine 6:50 AM CST 1 min read
Lake Street assumed sum of Limoneira (LMNR) with a Buy standing and a price target of $19, down from $23. The institution precocious reported Q4 results that were pressured by the last stages of the Sunkist transition, restructuring actions, and avocado replanting activity, though weaker near-term profitability has a constricted interaction to the firm’s longer-term thesis, the expert tells investors. Management guided to FY26 arsenic an inflection year, notes the analyst, who views Limoneira arsenic “increasingly positioned arsenic a diversified asset-backed concern with aggregate worth instauration drivers implicit the adjacent respective years.”
-
Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
-
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential
Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>
See Insiders’ Hot Stocks connected TipRanks >>
Read More connected LMNR:
Disclaimer & DisclosureReport an Issue
-
Closing Bell Movers: UiPath up astir 4% aft S&P 400 admission
-
Limoneira reports Q4 EPS (49c), 2 estimates (11c)
-
Limoneira sees FY26 citrus volumes astatine 4.0-4.5M cartons
-
The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
-
Is LMNR a Buy, Before Earnings?
English (CA) · 
English (US) · 
Spanish (MX) ·